BUSINESS / MARKETS / POLITICS16 November 2026
← Story archive

Business

Three FDA Decisions Loom After Summit’s Rejection — Capricor, Savara, Alzheimer’s Data Top Biotech’s Watchlist

Yahoo Finance

Capricor and Savara face Nov.22 FDA deadlines, while Beren Therapeutics awaits a Tuesday decision on Adrabetadex.

Read original reporting ↗

Follow the evidence

Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.

Coverage timeline

Published reporting in time order

No additional matched coverage has been archived for this story yet.

This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →